Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2707]
News [7018]
Articles [265]
Editorials [8]
Conferences [213]
elearning [41]
Rituximab in combination therapies for FL: Interim results
Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Rituximab in combination therapies for FL: Interim results ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018
Disease control in advanced Hodgkin lymphoma
Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Disease control in advanced Hodgkin lymphoma ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018
Mapping 3D genome dynamics in B cells
Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain
Mapping 3D genome dynamics in B cells ( Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain )
15 Jun 2018
Results from the phase I ICONIC trial
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
4 Jun 2018
What does progression-free survival mean for breast cancer patients?
Dr Peter Schmid - Barts Cancer Institute, London, UK
What does progression-free survival mean for breast cancer patients? ( Dr Peter Schmid - Barts Cancer Institute, London, UK )
4 Jun 2018
ASCO 2018: Latest developments in non-metastatic and metastatic castration...
Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik
ASCO 2018: Latest developments in non-metastatic and metastatic castration-resistant prostate cancer ( Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik )
3 Jun 2018
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer
Prof Kurt Miller and Prof Bertrand Tombal
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer ( Prof Kurt Miller and Prof Bertrand Tombal )
2 Jun 2018
Zoptarelin no better than doxarubicin for second-line advanced endometrial...
Dr David Miller - The University of Texas Southwestern Medical Center
Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer ( Dr David Miller - The University of Texas Southwestern Medical Center )
2 Jun 2018
First-in-human phase 1 study of TAK-931 for solid tumours
Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan
First-in-human phase 1 study of TAK-931 for solid tumours ( Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan )
2 Jun 2018
Web-mediated follow-up via patient-reported outcomes vs. routine surveillance...
Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France
Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in lung cancer patients ( Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France )
2 Jun 2018
Editor’s Choice for May 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
21 May 2018
The 2018 Myeloma Knowledge Exchange
Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology...
The 2018 Myeloma Knowledge Exchange ( Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria )
4 May 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation